Results 221 to 230 of about 802,845 (313)
Objective To evaluate the efficacy and safety of baricitinib in pediatric patients with active juvenile idiopathic arthritis–associated uveitis (JIA‐U) or chronic anterior antinuclear antibody–positive uveitis, who had an inadequate response to methotrexate (MTX) or biologic disease‐modifying antirheumatic drugs (bDMARDs).
Athimalaipet V. Ramanan +7 more
wiley +1 more source
Sex differences in treatment outcomes among U.S. service members with comorbid PTSD and MDD. [PDF]
Glassman LH +4 more
europepmc +1 more source
Objective Foot orthoses are thought to improve pain by potentially modifying internal mechanical forces. To test this, we explored whether foot orthoses can modify patterns of bone marrow lesions (BMLs) in people with midfoot pain. Methods Forty‐two people were recruited with midfoot pain, and magnetic resonance imaging–confirmed midfoot BMLs ...
Jill Halstead +4 more
wiley +1 more source
The threat to person-centered care: how censoring healthcare language endangers public health. [PDF]
Barello S, Romão ME.
europepmc +1 more source
Schaghticoke, Town of and Town of Schaghticoke Highway Department Unit, International Brotherhood of Teamsters (IBT), Local 294 (2013) [PDF]
core +1 more source
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multidisciplinary team‐based care.
Tarun Sharma +7 more
wiley +1 more source
The principle of stewardship truthful communication for the restoration of trust in public health officials. [PDF]
de Campos-Rudinsky TC.
europepmc +1 more source
Liability of the State and Its Employees for the Negligent Investigation of Child Abuse Reports [PDF]
Abbott, Susan Lynn
core +1 more source
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava +48 more
wiley +1 more source

